16-81011993-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001100624.3(CENPN):c.54G>A(p.Met18Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000114 in 1,614,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001100624.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CENPN | NM_001100624.3 | c.54G>A | p.Met18Ile | missense_variant | 2/11 | ENST00000305850.10 | NP_001094094.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CENPN | ENST00000305850.10 | c.54G>A | p.Met18Ile | missense_variant | 2/11 | 1 | NM_001100624.3 | ENSP00000305608 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000203 AC: 51AN: 251454Hom.: 0 AF XY: 0.000184 AC XY: 25AN XY: 135906
GnomAD4 exome AF: 0.000114 AC: 167AN: 1461824Hom.: 0 Cov.: 31 AF XY: 0.000116 AC XY: 84AN XY: 727218
GnomAD4 genome AF: 0.000112 AC: 17AN: 152184Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.54G>A (p.M18I) alteration is located in exon 2 (coding exon 1) of the CENPN gene. This alteration results from a G to A substitution at nucleotide position 54, causing the methionine (M) at amino acid position 18 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at